BRTX Stock Analysis: Buy, Sell, or Hold?
BRTX - BioRestorative Therapies, Inc. Common Stock (NV)
$0.21
0.00 (-0.98%)
▼
5d:
-3.09%
30d:
-26.48%
90d:
+2.5%
HOLD
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 25, 2026
0d
Get Alerted When BRTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BRTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BRTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BRTX is currently trading at $0.21, which is considered slightly low relative to its 30-day fair value range of $0.20 to $0.29.
Technical Outlook: Technically, BRTX is in a downtrend. Immediate support is located at $0.21, while resistance sits at $0.24.
Market Sentiment: BRTX scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.00 (+3652.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BRTX is in a downtrend. Immediate support is located at $0.21, while resistance sits at $0.24.
Market Sentiment: BRTX scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $8.00 (+3652.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.20 -
$0.29
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (70/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 3652.3% below Wall St target ($8.00)
- CAUTION: Bottoming setup, but lagging the sector by 23% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$0.20 -
$0.29
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.21
Resistance Level
$0.24
Current Trend
Downtrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.41
Wall Street Target
$8.00
(+3652.3%)
Revenue Growth (YoY)
-7.3%
Share & Embed Analysis
Last updated: August 24, 2026 11:15 PM ET
Data refreshes hourly during market hours. Next update: 12:15 AM
Data refreshes hourly during market hours. Next update: 12:15 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BRTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 39 SELL |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 55 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 46 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$108 | 53 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 46 HOLD |
